Metraipolis › archive › dc_1bdbedcff935

Relative Impact of GLP-1 Agonist Use on Microvascular Versus Macrovascular Complications — Europe PMC PMID:41147020

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41147020
DOI
10.7759/cureus.93925
License (as archived)
solo-consultazione
Archived
2026-11-09T13:31:13.454Z
SHA-256 of the archived text
0a3c571ce96fb7ee83bd7dfbff009fdfbd84646315dad90df5e0405537aec198
Stable URL of this page
https://metraipolis.com/documento/dc_1bdbedcff935

How to cite

Relative Impact of GLP-1 Agonist Use on Microvascular Versus Macrovascular Complications — Europe PMC PMID:41147020 — Europe PMC (en), https://europepmc.org/article/MED/41147020 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1bdbedcff935 (Metraipolis archive dc_1bdbedcff935, sha256 0a3c571ce96fb7ee83bd7dfbff009fdfbd84646315dad90df5e0405537aec198)
BibTeX
@misc{dc1bdbedcff935,
  title = {Relative Impact of GLP-1 Agonist Use on Microvascular Versus Macrovascular Complications — Europe PMC PMID:41147020},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41147020},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1bdbedcff935; sha256 0a3c571ce96fb7ee83bd7dfbff009fdfbd84646315dad90df5e0405537aec198},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41147020. Agents can read the archived copy with the MCP tool read_document.